Experimental compound reduces cell death, inflammation, and organ damage in diabetes
An experimental compound reduced the cell death, inflammation, and organ damage seen with diabetes. Led by NYU Langone…
CRISPR therapy shows promise against influenza in human lung chips
The Influenza A virus (IAV) has been the cause of six major flu pandemics, responsible for 50 to…
Purespring Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines Conference
Purespring Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines Conference London – 14 October 2025 – Purespring…
Repeated sampling offers insight into glioblastoma therapy response
A multi-institutional study from the Accelerating GBM Therapies Through Serial Biopsies TeamLab, led by investigators from the Mass…
AI-designed proteins revolutionize gene editing precision and safety
Researchers at Integra Therapeutics, in collaboration with the Pompeu Fabra University (UPF) Department of Medicine and Life Sciences…
Study reveals a new oncogenic role of NBL1 in ovarian cancer metastasis
Ovarian cancer (OC), one of the three most common gynecological malignancies, is characterized by low early detection rates…
Enhanced Genomics extends Series A funding to USD $19 million to drive development of therapeutics pipeline
Sep 17 2025 Enhanced Genomics (‘Enhanced’), the biotechnology company pioneering 3D multi-omics to rapidly identify high-confidence, genetically validated…
Unlocking hidden soil microbes for new antibiotics
Most bacteria cannot be cultured in the lab-and that’s been bad news for medicine. Many of our frontline…
Mentavi study validates first fully digital diagnostic pathway for adult ADHD
Mentavi Health announced that its landmark, real-world validation study of the Mentavi Diagnostic Evaluation has been published in…